These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26991860)

  • 1. A method to measure thrombin activity in a mixture of fibrinogen and thrombin powders.
    DeAnglis AP; Nur I; Gorman AJ; Meidler R
    Blood Coagul Fibrinolysis; 2017 Mar; 28(2):134-138. PubMed ID: 26991860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro clot model to evaluate fibrin-thrombin effects on fractal dimension of incipient blood clot.
    Sabra A; Lawrence MJ; Curtis D; Hawkins K; Williams PR; Evans PA
    Clin Hemorheol Microcirc; 2019 Jul; -1():147-153. PubMed ID: 31381508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Thrombin within fibrin clots: inactivation of thrombin by antithrombin-III.
    Naski MC; Shafer JA
    Thromb Res; 1993 Mar; 69(5):453-65. PubMed ID: 8497860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen.
    Stang LJ; Mitchell LG
    Methods Mol Biol; 2013; 992():181-92. PubMed ID: 23546714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Fibrinogen Concentrate on Thrombin Generation, Thromboelastometry Parameters, and Laboratory Coagulation Testing in a 24-Hour Porcine Trauma Model.
    Zentai C; Solomon C; van der Meijden PE; Spronk HM; Schnabel J; Rossaint R; Grottke O
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):749-759. PubMed ID: 25948634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosis.
    Vucelic D; Jesic R; Jovicic S; Zivotic M; Grubor N; Trajkovic G; Canic I; Elezovic I; Antovic A
    Thromb Res; 2015 Jun; 135(6):1124-30. PubMed ID: 25900310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure.
    Ho W; Tawil B; Dunn JC; Wu BM
    Tissue Eng; 2006 Jun; 12(6):1587-95. PubMed ID: 16846354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin generation.
    Berry LR; Chan AK
    Methods Mol Biol; 2013; 992():139-54. PubMed ID: 23546711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Overwiew of the Coagulation System and laboratory tests for its study].
    Guerrero B; López M
    Invest Clin; 2015 Dec; 56(4):432-54. PubMed ID: 29938976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High sensitivity micro-elastometry: applications in blood coagulopathy.
    Wu G; Krebs CR; Lin FC; Wolberg AS; Oldenburg AL
    Ann Biomed Eng; 2013 Oct; 41(10):2120-9. PubMed ID: 23649979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 96-well microfiltration assay for measurement of total clottable fibrinogen.
    Dempfle CE; Keller A; Argirion S; Heene DL
    Thromb Haemost; 1999 Feb; 81(2):264-7. PubMed ID: 10064004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fibrin(ogen) on thrombin generation and decay.
    Kremers RM; Wagenvoord RJ; Hemker HC
    Thromb Haemost; 2014 Sep; 112(3):486-94. PubMed ID: 24964786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
    Szczepaniak P; Zabczyk M; Undas A
    PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked coagulation assay: a clot-based, solid-phase assay for thrombin.
    Doellgast GJ; Rothberger H
    Anal Biochem; 1985 Jun; 147(2):529-34. PubMed ID: 4014693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound.
    Muthard RW; Welsh JD; Brass LF; Diamond SL
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):645-54. PubMed ID: 25614284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.